MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Government: U.S. States & Territories
Government: States (U.S.)
Maryland
Metropolitan Areas: Maryland
Montgomery County, Maryland
*Industry: Montgomery County
*Industry: Rockville, Maryland
Immunomic Therapeutics, Inc
Organization & Developments: Immunomic Therapeutics
Parents
Immunomic Therapeutics, Inc
Children
2020: Maryland’s Immunomic Therapeutics Exceeds Fundraising Goal, Envisions Future IPO · BioBuzz
2022: Immunomic Therapeutics, Inc. Receives FDA Fast Track Designation for ITI-3000, a pDNA Vaccine, in Development for the Treatment of Merkel Cell Carcinoma_ Biohealth Innovation
Biotechnology company developing vaccines based on LAMP technology
Immunomic Therapeutics, Inc. (ITI) is a privately-held, clinical-stage biotechnology company pioneering the development of vaccines through its proprietary technology platform UNITE, which is designed to utilize the body’s natural biochemistry to develop vaccines that generate broad immune responses.
ITI is primarily focused on applying the UNITE platform to oncology indications, where it could potentially have broad applications, including development of antigen-derived antibodies as biologics in a number of cancers.
LAMP is a naturally occurring intracellular protein used to target antigens & trigger immune system activation
Jumps
*Key People: Immunomic Therapeutics
Finance & Acquisitions: Immunomic Therapeutics